Annual Net Income:
$163.89M+$92.48M(+129.50%)Summary
- As of today, CPRX annual net profit is $163.89 million, with the most recent change of +$92.48 million (+129.50%) on December 31, 2024.
- During the last 3 years, CPRX annual net income has risen by +$124.41 million (+315.10%).
- CPRX annual net income is now at all-time high.
Performance
CPRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
$52.78M+$675.00K(+1.30%)Summary
- As of today, CPRX quarterly net profit is $52.78 million, with the most recent change of +$675.00 thousand (+1.30%) on September 30, 2025.
- Over the past year, CPRX quarterly net income has increased by +$8.90 million (+20.28%).
- CPRX quarterly net income is now -6.97% below its all-time high of $56.74 million, reached on March 31, 2025.
Performance
CPRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
$217.56M+$8.90M(+4.26%)Summary
- As of today, CPRX TTM net profit is $217.56 million, with the most recent change of +$8.90 million (+4.26%) on September 30, 2025.
- Over the past year, CPRX TTM net income has increased by +$74.77 million (+52.36%).
- CPRX TTM net income is now at all-time high.
Performance
CPRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CPRX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +129.5% | +20.3% | +52.4% |
| 3Y3 Years | +315.1% | +132.0% | +225.1% |
| 5Y5 Years | +414.2% | +21.8% | +204.4% |
CPRX Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +315.1% | -7.0% | +271.6% | at high | +250.7% |
| 5Y | 5-Year | at high | +414.2% | -7.0% | +271.6% | at high | +451.1% |
| All-Time | All-Time | at high | +582.0% | -7.0% | +271.6% | at high | +739.8% |
CPRX Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $52.78M(+1.3%) | $217.56M(+4.3%) |
| Jun 2025 | - | $52.11M(-8.2%) | $208.66M(+5.7%) |
| Mar 2025 | - | $56.74M(+1.4%) | $197.35M(+20.4%) |
| Dec 2024 | $163.89M(+129.5%) | $55.94M(+27.5%) | $163.89M(+14.8%) |
| Sep 2024 | - | $43.88M(+7.6%) | $142.80M(+109.5%) |
| Jun 2024 | - | $40.79M(+75.3%) | $68.15M(+4.7%) |
| Mar 2024 | - | $23.27M(-33.2%) | $65.12M(-8.8%) |
| Dec 2023 | $71.41M(-14.0%) | $34.84M(+213.3%) | $71.41M(+15.1%) |
| Sep 2023 | - | -$30.76M(-181.5%) | $62.04M(-46.3%) |
| Jun 2023 | - | $37.76M(+27.7%) | $115.55M(+16.2%) |
| Mar 2023 | - | $29.57M(+16.1%) | $99.41M(+19.7%) |
| Dec 2022 | $83.08M(+110.4%) | $25.47M(+12.0%) | $83.08M(+24.2%) |
| Sep 2022 | - | $22.75M(+5.2%) | $66.92M(+22.8%) |
| Jun 2022 | - | $21.62M(+63.3%) | $54.50M(+20.9%) |
| Mar 2022 | - | $13.24M(+42.2%) | $45.06M(+14.1%) |
| Dec 2021 | $39.48M(-47.3%) | $9.31M(-9.9%) | $39.48M(-5.1%) |
| Sep 2021 | - | $10.33M(-15.2%) | $41.61M(-44.2%) |
| Jun 2021 | - | $12.18M(+59.0%) | $74.62M(+3.3%) |
| Mar 2021 | - | $7.66M(-33.0%) | $72.22M(-3.7%) |
| Dec 2020 | $74.98M(+135.2%) | $11.44M(-73.6%) | $74.98M(+4.9%) |
| Sep 2020 | - | $43.34M(+343.1%) | $71.48M(+71.1%) |
| Jun 2020 | - | $9.78M(-6.2%) | $41.77M(-2.7%) |
| Mar 2020 | - | $10.43M(+31.5%) | $42.95M(+34.7%) |
| Dec 2019 | $31.88M(+193.7%) | $7.93M(-41.8%) | $31.88M(+237.4%) |
| Sep 2019 | - | $13.63M(+24.4%) | $9.45M(+178.6%) |
| Jun 2019 | - | $10.96M(+1800.5%) | -$12.02M(+58.5%) |
| Mar 2019 | - | -$644.50K(+95.6%) | -$28.95M(+14.9%) |
| Dec 2018 | -$34.00M(-84.7%) | -$14.50M(-85.0%) | -$34.00M(-36.6%) |
| Sep 2018 | - | -$7.84M(-31.4%) | -$24.89M(-17.2%) |
| Jun 2018 | - | -$5.97M(-4.7%) | -$21.23M(-10.9%) |
| Mar 2018 | - | -$5.70M(-5.8%) | -$19.15M(-4.0%) |
| Dec 2017 | -$18.41M(-1.9%) | -$5.39M(-29.0%) | -$18.41M(-7.1%) |
| Sep 2017 | - | -$4.18M(-7.7%) | -$17.19M(-1.3%) |
| Jun 2017 | - | -$3.88M(+21.9%) | -$16.96M(+3.9%) |
| Mar 2017 | - | -$4.97M(-19.3%) | -$17.65M(+2.3%) |
| Dec 2016 | -$18.07M(+10.7%) | -$4.16M(-5.3%) | -$18.07M(+8.4%) |
| Sep 2016 | - | -$3.95M(+13.5%) | -$19.72M(+2.4%) |
| Jun 2016 | - | -$4.57M(+15.2%) | -$20.22M(-0.1%) |
| Mar 2016 | - | -$5.39M(+7.4%) | -$20.21M(+0.1%) |
| Dec 2015 | -$20.23M(-30.5%) | -$5.82M(-30.7%) | -$20.23M(-13.0%) |
| Sep 2015 | - | -$4.45M(+2.4%) | -$17.91M(+3.0%) |
| Jun 2015 | - | -$4.56M(+15.7%) | -$18.47M(-8.0%) |
| Mar 2015 | - | -$5.41M(-55.0%) | -$17.11M(-10.3%) |
| Dec 2014 | -$15.51M | -$3.49M(+30.3%) | -$15.51M(-16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | -$5.01M(-56.7%) | -$13.37M(+6.3%) |
| Jun 2014 | - | -$3.20M(+16.1%) | -$14.28M(-0.4%) |
| Mar 2014 | - | -$3.81M(-181.3%) | -$14.22M(-17.0%) |
| Dec 2013 | -$12.15M(-198.2%) | -$1.35M(+77.1%) | -$12.15M(-11.8%) |
| Sep 2013 | - | -$5.91M(-88.1%) | -$10.88M(-43.4%) |
| Jun 2013 | - | -$3.14M(-80.2%) | -$7.59M(-60.3%) |
| Mar 2013 | - | -$1.74M(-2177.2%) | -$4.73M(-16.1%) |
| Dec 2012 | -$4.08M(+36.2%) | -$76.60K(+97.1%) | -$4.08M(+35.8%) |
| Sep 2012 | - | -$2.62M(-806.8%) | -$6.35M(-30.7%) |
| Jun 2012 | - | -$289.10K(+73.5%) | -$4.86M(+18.5%) |
| Mar 2012 | - | -$1.09M(+53.7%) | -$5.96M(+6.7%) |
| Dec 2011 | -$6.39M(-59.5%) | -$2.35M(-108.5%) | -$6.39M(-34.0%) |
| Sep 2011 | - | -$1.13M(+19.1%) | -$4.77M(-4.9%) |
| Jun 2011 | - | -$1.39M(+8.1%) | -$4.54M(-1.5%) |
| Mar 2011 | - | -$1.52M(-108.2%) | -$4.48M(-11.8%) |
| Dec 2010 | -$4.01M(+44.7%) | -$728.80K(+19.4%) | -$4.01M(+9.8%) |
| Sep 2010 | - | -$904.00K(+32.0%) | -$4.44M(+7.9%) |
| Jun 2010 | - | -$1.33M(-27.1%) | -$4.82M(+8.2%) |
| Mar 2010 | - | -$1.04M(+10.1%) | -$5.26M(+27.4%) |
| Dec 2009 | -$7.24M(+31.5%) | -$1.16M(+9.7%) | -$7.24M(+26.3%) |
| Sep 2009 | - | -$1.29M(+27.0%) | -$9.83M(+13.8%) |
| Jun 2009 | - | -$1.76M(+41.9%) | -$11.40M(+5.1%) |
| Mar 2009 | - | -$3.03M(+19.1%) | -$12.01M(-13.7%) |
| Dec 2008 | -$10.56M(-155.2%) | -$3.75M(-31.3%) | -$10.56M(-36.1%) |
| Sep 2008 | - | -$2.86M(-20.1%) | -$7.76M(-37.6%) |
| Jun 2008 | - | -$2.38M(-50.1%) | -$5.64M(-26.2%) |
| Mar 2008 | - | -$1.58M(-67.6%) | -$4.47M(-8.0%) |
| Dec 2007 | -$4.14M(-51.7%) | -$944.90K(-28.7%) | -$4.14M(-5.2%) |
| Sep 2007 | - | -$734.30K(+39.2%) | -$3.94M(+13.0%) |
| Jun 2007 | - | -$1.21M(+3.5%) | -$4.52M(-23.3%) |
| Mar 2007 | - | -$1.25M(-68.9%) | -$3.67M(-33.4%) |
| Dec 2006 | -$2.73M(-51.2%) | -$741.20K(+43.9%) | -$2.75M(+17.4%) |
| Sep 2006 | - | -$1.32M(-273.3%) | -$3.33M(-48.0%) |
| Jun 2006 | - | -$354.00K(-6.2%) | -$2.25M(+12.0%) |
| Mar 2006 | - | -$333.40K(+74.8%) | -$2.56M(+11.3%) |
| Dec 2005 | -$1.81M(-234.5%) | -$1.32M(-446.4%) | -$2.89M(-69.9%) |
| Sep 2005 | - | -$241.90K(+63.4%) | -$1.70M(-6.7%) |
| Jun 2005 | - | -$660.80K(0.0%) | -$1.59M(-49.3%) |
| Mar 2005 | - | -$660.80K(-389.5%) | -$1.07M(-97.4%) |
| Dec 2004 | -$539.80K(-25.9%) | -$135.00K(0.0%) | -$540.00K(-33.3%) |
| Sep 2004 | - | -$135.00K(0.0%) | -$405.00K(-50.0%) |
| Jun 2004 | - | -$135.00K(0.0%) | -$270.00K(-100.0%) |
| Mar 2004 | - | -$135.00K | -$135.00K |
| Dec 2003 | -$428.60K(-67.5%) | - | - |
| Dec 2002 | -$255.90K | - | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual net profit?
- What is the all-time high annual net income for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual net income year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly net income year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. TTM net profit?
- What is the all-time high TTM net income for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. TTM net income year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual net profit?
The current annual net income of CPRX is $163.89M
What is the all-time high annual net income for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual net profit is $163.89M
What is Catalyst Pharmaceuticals, Inc. annual net income year-on-year change?
Over the past year, CPRX annual net profit has changed by +$92.48M (+129.50%)
What is Catalyst Pharmaceuticals, Inc. quarterly net profit?
The current quarterly net income of CPRX is $52.78M
What is the all-time high quarterly net income for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly net profit is $56.74M
What is Catalyst Pharmaceuticals, Inc. quarterly net income year-on-year change?
Over the past year, CPRX quarterly net profit has changed by +$8.90M (+20.28%)
What is Catalyst Pharmaceuticals, Inc. TTM net profit?
The current TTM net income of CPRX is $217.56M
What is the all-time high TTM net income for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high TTM net profit is $217.56M
What is Catalyst Pharmaceuticals, Inc. TTM net income year-on-year change?
Over the past year, CPRX TTM net profit has changed by +$74.77M (+52.36%)